Neuroradiology: Page 55

AC Immune's PET tracer to be presented at AAIC

By AuntMinnie.com staff writers

A researcher from Swiss biopharmaceutical company AC Immune will present findings on the company's alpha-synuclein-PET tracer program at the virtual 2020 Alzheimer's Association International Conference (AAIC).

July 22, 2020

Brain lesions on DWI-MRI linked to poor outcomes for some

By Rebekah Moan

Lesions that appear on diffusion-weighted imaging (DWI) MRI scans represent acute sequelae of chronic cerebral small-vessel disease, according to a July 20 study in JAMA Neurology. In addition, the presence of DWI lesions signifies worse prognosis after intracerebral hemorrhage.

July 20, 2020

ECR 2020: COVID-19's nonpulmonary manifestations

By Kate Madden Yee

COVID-19 often initially presents as respiratory disease, but it also has serious nonpulmonary manifestations, according to a session held on July 16 at the virtual edition of ECR 2020.

July 17, 2020

SNMMI 2020: PET radiotracer measures stroke recovery

By Theresa Pablos

A new PET radiotracer may one day help clinicians evaluate stroke recovery, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting. Researchers used the radiotracer, F-18 SynVesT-2, to assess synaptic density in rat brains.

July 14, 2020

SNMMI 2020: PET tracer could image, treat glioblastoma

By Erik L. Ridley

A new, relatively long-lived PET tracer can safely and effectively image patients with glioblastoma, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The tracer also shows potential as a radiotheragnostic agent.

July 14, 2020

SNMMI 2020: Image of the Year scans reveal 'super-agers'

By Wayne Forrest

A group of German researchers has received the Image of the Year award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for a series of PET images that show that older adults who maintained peak cognitive skills exhibited greater resistance to buildup of tau and amyloid proteins.

July 13, 2020

SNMMI 2020: AI can aid in diagnosis of Parkinson's disease

By Erik L. Ridley

An artificial intelligence (AI) algorithm was highly accurate for diagnosing Parkinson's disease on dopamine transporter SPECT exams, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

July 13, 2020

Avicenna.ai lands FDA nod for Cina Head triage software

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer Avicenna.ai has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its Cina Head AI computer-assisted triage software.

July 13, 2020

Researchers outline neurological signs of COVID-19

By Kate Madden Yee

U.K. researchers are offering an outline of neurological manifestations of severe SARS-CoV-2 infection they hope will help their colleagues better recognize and treat COVID-19, the disease caused by the virus, according to a study published July 8 in Brain.

July 8, 2020

fMRI illuminates COVID-19 patients' brain function

By AuntMinnie.com staff writers

Functional MRI (fMRI) shows that patients with severe COVID-19 with prolonged unresponsiveness may have a better chance at recovery than expected, according to a study published July 1 in the Annals of Neurology.

July 6, 2020

RapidAI gets FDA clearance for stroke imaging AI

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer RapidAI has garnered U.S. Food and Drug Administration (FDA) clearance for its Rapid ASPECTS stroke imaging computer-aided diagnosis (CADx) software.

July 6, 2020

NIH seeks applicants for BRAIN research program

By AuntMinnie.com staff writers

The U.S. National Institutes of Health (NIH) has announced new funding opportunities for its $4.5 billion Brain Research Through Advancing Neurotechnologies (BRAIN) initiative.

July 1, 2020

Previous Page

Page 55 of 238

Next Page